Volgen
Michael Hartung
Michael Hartung
Geverifieerd e-mailadres voor uni-hamburg.de
Titel
Geciteerd door
Geciteerd door
Jaar
Democratizing knowledge representation with BioCypher
S Lobentanzer, P Aloy, J Baumbach, B Bohar, VJ Carey, P Charoentong, ...
Nature Biotechnology 41 (8), 1056-1059, 2023
162023
SPONGEdb: a pan-cancer resource for competing endogenous RNA interactions
M Hoffmann, E Pachl, M Hartung, V Stiegler, J Baumbach, MH Schulz, ...
NAR cancer 3 (1), zcaa042, 2021
122021
Cancer driver drug interaction explorer
M Hartung, E Anastasi, ZM Mamdouh, C Nogales, HHHW Schmidt, ...
Nucleic Acids Research 50 (W1), W138-W144, 2022
102022
Drugst. One-A plug-and-play solution for online systems medicine and network-based drug repurposing
A Maier, M Hartung, M Abovsky, K Adamowicz, GD Bader, S Baier, ...
Arxiv, 2023
42023
Inference of differential key regulatory networks and mechanistic drug repurposing candidates from scRNA-seq data with SCANet
M Oubounyt, L Adlung, F Patroni, NK Wenke, A Maier, M Hartung, ...
Bioinformatics 39 (11), btad644, 2023
12023
A plug-and-play solution to bring network exploration and drug repurposing to biomedical web platforms
M Hartung, A Maier, S Sadegh, J Matschinske, M List, OA Zolotareva, ...
RExPO22, 2022
12022
Network medicine-based epistasis detection in complex diseases: ready for quantum computing
M Hoffmann, JM Poschenrieder, M Incudini, S Baier, A Fitz, A Maier, ...
Medrxiv, 2023
2023
Network pharmacology and drug repurposing pave the way for precision oncology
ZM Mamdouh, C Nogales, C Macchiusi, MH Elbatreek, ...
RExPO22, 2022
2022
DESMOND 2.0: Identification of differentially expressed biclusters for unsupervised patient stratification
O Zolotareva, OV Isaeva, M Hartung, A Maier, F Delgado-Chaves, ...
RExPO22, 2022
2022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–9